SPI
AZN icon

Santori & Peters Inc’s AstraZeneca AZN Stock Holding History

Santori & Peters Inc’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-58
Closed -$3K – 98
2017
Q4 		$3K Buy
+58
New +$3.91K ﹤0.01% 508

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Santori & Peters Inc's AZN Position: Q1 2018 in Review

Santori & Peters Inc sold out of AstraZeneca (AZN) in Q1 2018, closing a stake of 58 shares — an estimated $3K sold.

Santori & Peters Inc first reported a position in AZN in Q4 2017 and held it in 1 quarter. The position peaked at $3K in Q4 2017. 519 funds tracked by Wall St. Rank hold AZN as of Q1 2018.

  • Santori & Peters Inc reported no remaining AstraZeneca position as of Q1 2018 after selling out during the quarter.
  • Santori & Peters Inc sold 58 AstraZeneca shares in Q1 2018, an estimated $3K.
  • Santori & Peters Inc first reported a position in AstraZeneca in Q4 2017 and held it in 1 quarter.
  • Santori & Peters Inc's AstraZeneca position peaked at $3K in Q4 2017.
  • 519 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2018.

Based on Santori & Peters Inc's 13F filing for Q1 2018, filed 16 Apr 2018.